Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,518 | -6,967 | -66,418 | -58,045 | -45,460 |
| Depreciation Amortization | 151 | -253 | -3,073 | -2,747 | -1,825 |
| Accounts receivable | -10,972 | -30,287 | -38,297 | -25,860 | -11,574 |
| Accounts payable and accrued liabilities | 23,410 | 7,714 | 6,906 | N/A | 269 |
| Other Working Capital | 39,152 | -29,476 | 14,638 | 1,063 | -18,265 |
| Other Operating Activity | 10,348 | 34,617 | 73,793 | 53,808 | 26,817 |
| Operating Cash Flow | $36,571 | $-24,652 | $-12,451 | $-31,781 | $-50,038 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,887 | -5,818 | -9,859 | -3,501 | -1,591 |
| Purchase Of Investment | -129,201 | -126,799 | -394,056 | -357,606 | -255,273 |
| Sale Of Investment | 118,404 | 74,055 | 361,800 | 269,718 | 170,218 |
| Investing Cash Flow | $-20,684 | $-58,562 | $-42,115 | $-91,389 | $-86,646 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,506 | 1,204 | 143,388 | 141,076 | 138,514 |
| Financing Cash Flow | $4,506 | $1,204 | $143,388 | $141,076 | $138,514 |
| Beginning Cash Position | 186,203 | 186,203 | 97,381 | 97,381 | 97,381 |
| End Cash Position | 206,596 | 104,193 | 186,203 | 115,287 | 99,211 |
| Net Cash Flow | $20,393 | $-82,010 | $88,822 | $17,906 | $1,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,571 | -24,652 | -12,451 | -31,781 | -50,038 |
| Capital Expenditure | -9,887 | -5,818 | -9,859 | -3,501 | -1,591 |
| Free Cash Flow | 26,684 | -30,470 | -22,310 | -35,282 | -51,629 |